This page contains publicly available information released following a freedom of information (FOI) access request.

About the disclosure log

The Australian Pesticides and Veterinary Medicines Authority (APVMA) is required by section 11C of the Freedom of Information Act 1982 (the FOI Act) to publish a freedom of information disclosure log on its website. The disclosure log lists information that has been released in response to FOI access requests. This requirement has applied since 1 May 2011.

The disclosure log requirement does not apply to:

  • personal information about any person if publication of that information would be ‘unreasonable’
  • information about the business, commercial, financial or professional affairs of any person if publication of that information would be ‘unreasonable’
  • other information covered by a determination made by the Australian Information Commissioner if publication of that information would be ‘unreasonable’
  • any information if it is not reasonably practicable to publish the information because of the extent of modifications that would need to be made to delete the information listed in the above dot points.

The information described in the below disclosure log table has been released by the APVMA under the FOI Act and is available for public access.

Any documents uploaded to the APVMA disclosure log may be removed after 12 months of publication.

Information that is not available online may be obtained by emailing FOI@apvma.gov.au. A charge may be imposed to reimburse the APVMA for the cost incurred in copying or reproducing the information or sending it to you. There will be no charge for the time spent by the APVMA in processing the FOI request that led to this information being made available. You will be notified if any charge is payable and you will be required to pay the charge before the information is provided.

There may be documents in the disclosure log that are currently not available in HTML format. If you are unable to read the format provided please contact FOI@apvma.gov.au. The APVMA will try to meet all reasonable requests for an alternate format of the document in a timely manner and at the lowest reasonable cost to you.

Disclosure log table

Note: Documents released as a result of any of the below FOI requests are available from the APVMA upon written request.

APVMA reference numberDate publishedSummary of FOI requestDescription of documents (released in full or in part)
FOI 2024/01728 April 2025The number of adverse experience reports classified as ‘related to’ the active fluralaner for the 2023 and 2024 calendar years.1 document released in full
FOI 2024/01016 January 2025Emails regarding paraquat and diquat between the APVMA and stakeholders.2 documents released in full, 38 documents released in part
FOI 2024/01621 January 2025Documents relating to delay in Anticoagulant Chemicals Review.1 document released in part
FOI 2024/0057 November 2024Documents referred to on page 7 of the APVMA Special Gazette 10 October 2024 in relation to the APVMA decision regarding chlorthal dimethyl2 documents released in full, 1 document released in part, access refused to 1 document
FOI 2023/01917 May 2024

Documents dated between 1 January 2022 and 20 February 2024 in relation to the procurement of Terrace Services to perform the following contracts:

  • Multi-Faceted Support: IT leadership and sustainable funding model review 
  • Engagement of specialist services to assist in procurement of ICT managed services
1 document released in full, 30 documents released in part, access refused to 3 documents
FOI 2023/02217 May 2024Style Guides/Brand Guides/Writing Guides currently used for the Australian Pesticides and Veterinary Medicines Authority.2 documents released in full
FOI 2023/0026 October 2023The “Environmental Risk Assessment” that details the impacts of exposure on non-target species undertaken for the issue of the permit issued to DEECA Victoria for use of a rodenticide on Deen Maar Island, Victoria (PER92722)1 document released in full
FOI 2022/01311 August 2023Documents in relation to Sentinel products (62390, 62391, 62392, 62393)28 documents released in full, 49 documents released in part
FOI 2022/00719 January 2023A copy of the Human Health Risk Assessment Technical Report used to assess the registration approval of Barricade Herbicide (APVMA product #62982)1 document partially released
FOI 2022/00324 October 2022Documents and applications in relation to the permit to allow supply and minor use of an unregistered agvet chemical product for control of redback spiders in table grapes (PER85499)1 document released in full and 2 documents released in part
FOI 2022/0055 October 2022Adverse events reported for animal health each year for the active constituent fluralaner including presenting signs, for years 2016–204 documents released in full
FOI 2021/02811 August 2022Documents in relation to Teatsoft Udder Conditioner (APVMA product #90131)3 documents released in full, 23 documents released in part, access refused to 2 documents
FOI 2021/02711 August 2022Documents in relation to AlkaKleen Concentrated Low Foam Alkaline Cleaner (APVMA product #88092)6 documents released in full, 19 documents released in part, access refused to 2 documents
FOI 2021/02118 May 2022Documents and applications in relation to the permit to allow minor use of a registered agvet chemical to eradicate incursions of invasive rodents from Lord Howe Island and associated islets, and the ‘Lord Howe Island rodent incursion response guidance – revision August 2020’5 documents partially released
FOI 2021/01726 April 2022A copy of the Human Health Risk Assessment Technical Report used to assess the registration approval of Dedicate Forte Stressgard Turf Fungicide (APVMA product #89422)1 document partially released
FOI 2021/01228 March 2022Documents in relation to TeatReady Premixed Teat Dip and Spray (APVMA product #89117).2 documents released in full and 14 documents released in part
FOI 2021/01624 March 2022Adverse experience reports and correspondence in relation to NV PENTOSAN EVOLUTION INJECTION FOR HORSES (APVMA product #65881)20 documents partially released
FOI 2021/01015 March 2022A copy of the Human Health Risk Assessment Technical Report used to assess the registration approval of Quali-Pro Negate Herbicide (APVMA product #88290)1 document partially released
FOI 2021/01114 March 2022Documents in relation to DualQuat-10 Sanitiser (APVMA product #89404)4 documents released in full and 11 documents released in part
FOI 2021/00721 January 2022Copies of Part 8 Efficacy and Crop safety submission in relation to Overwatch Herbicide (APVMA product #86427)

1 document released in part and access refused to 2 documents

 

FOI 2021/0062 December 2021Copies of emails and attachments in relation to Overwatch Herbicide (APVMA product #86427)

24 documents released in part and access refused to 1 document

 

FOI 2021/0045 November 2021Documents in relation to TeatDyne Concentrate Teat Dip and Spray (APVMA product #89925)3 documents released in full and 20 documents released in part
FOI 2021/00120 October 2021Documents in relation to BRAVECTO 250MG Fluralaner Chewable Tablets for Small Dogs (APVMA product #68872)1 document partially released
FOI 2020/03311 August 2021Documents related to the 'Consultation on use patterns for anticoagulant rodenticide products'84 documents partially released
FOI 2020/03231 August 2021A copy of the data list presented for the registration of product number 51321, and active constituent product numbers 50921, 53732 and 613745 document titles released in full in relation to product number 61374
FOI 2020/03126 August 2021Documents held by the APVMA on adverse experiences related to alpha-choralose poison baiting practices4 documents partially released
FOI 2020/03015 June 2021Copies of discontinued product labels for 'Entrust' – label #0503, #0404 and #05063 documents released in full
FOI 2020/0297 June 2021All documents and reports held by the APVMA on the health and safety risks and/or impacts of alpha-chloralose on native Australian wildlife including native Australian bird species3 documents partially released
FOI 2020/02826 April 2021

In relation to the Public Governance, Performance and Accountability Rule 2014, seeking for each calendar year from 2016 to 2019 inclusively, the first page that contains the completion date of the first finalised:

  1. Fraud-risk assessment for the purposes of s10(a) of the Rule, and
  2. Fraud/compliance audit implemented for purposes of s10(b/d) of the Rule

Tabular form is acceptable

1 document released in full
FOI 2020/01413 July 2020Access to registration application form, containing formulation details, for product number 59621 – Homeguard Termite Moisture BarrierAccess refused to 2 documents
FOI2020/00926 May 2020
  1. Amount of MEMC that has been imported into Australia, per year, since 1997
  2. Amount of MEMC that has been manufactured in Australia, per year, since 1997
  3. Amount of MEMC that has been exported from Australia, per year, since 1997
  4. The quantity of MEMC declared by registrants, per year, since 1997, for the calculation of levies charged on MEMC

Access refused to 15 documents relating to items 1–4


Access to part of category 4 refused on the grounds that documents cannot be found or do not exist

FOI2020/00820 March 2020
  1. The year of registration of product ‘Shirtan Liquid Fungicide’ (No. 49572) with the APVMA
  2. The year that the product was approved by the APVMA to be sold in Australia
  3. Annual quantity of the product sold, as reported to the APVMA since the registration of this product up to 2019  

Items 1 and 2 – Documents released in full

 

Item 3 – Access to documents refused on the grounds that documents cannot be found or do not exist

FOI2020/00213 February 2020List of all cockroach pesticides and insecticides that were recalled, suspended, cancelled or repackaged in 1996Access to documents refused on the grounds that documents cannot be found or do not exist
FOI2019/00311 November 2019Roundup health/toxicology reports.6 documents released in part
FOI2019/00410 September 2019
  1. Data from the Agricultural Chemical Usage database
  2. Volume of individual pesticides (or total pesticides) with high spatial resolution ie by state, region, or catchment scale
  3. Sales data with higher spatial resolution ie by state, region, or catchment scale  
Access to documents refused on the grounds that documents cannot be found or do not exist
LEX 569016 August 2019
  1. A copy of the results of the staff survey undertaken in early 2018 and the APVMA’s consequential action plan and updated risk assessment matrix relating to its relocation to Armidale
1 document released in part
LEX 569116 August 2019
  1. A copy of an email trail
1 document released in part
LEX568524 July 2019Copy of health assessment reports relating to the product ‘Superbud’ manufactured by DutchmasterNo documents identified
LEX 566915 July 2019
  1. A copy of all assessment reports by the APVMA in relation to methoprene, and
  2. A list of information, eg test and study reports held by the APVMA 
8 documents released in full
LEX 563511 June 2019

Documents in relation to industry-funded travel and/or conferences for APVMA staff in the last five years. Summaries of what has occurred in the past five years may satisfy this request

 

Documents relating to any gifts received from industry to APVMA individual staff, executives, or the department

1 document released in full and 5 documents released in part
LEX 559217 April 2019The most recent document or progress report to the Chief Executive Officer and/or Deputy Chief Executive Officer of the APVMA on the relocation of the agency that includes information about the impact of the relocation on staff and the organisation’s capacity to perform its functions1 document released in full.
LEX 54495 December 2018

All written correspondence between CropLife Australia and the APVMA in the months:

  • September 2016
  • October 2016
  • November 2016
  • March 2017
  • April 2017
  • March 2018; and
  • August 2018 

including, in the case of emails with attachments, the first two pages of those attachments

46 documents released in full, 390 documents released in part and access refused to 4 documents
LEX 54576 November 2018 
  1. adverse experience reports relating to the NexGard and NexGard Spectra product ranges between August and December 2017; and
  2. communications between the APVMA and the manufacturer concerning any adverse test results and/or any failure of those products to meet all of the statutory criteria for registration

25 documents released in full and 24 documents released in part under category a

 

Access to category b refused on the grounds that documents cannot be found or do not exist

LEX 53914 July 2018Documents containing the identity of a complainant or complainants, and the substance of two complaints made to the APVMA

14 documents released in part

 

Access refused in relation to one document on the grounds that it would disclose lawful methods or procedures for investigating, or dealing with matters arising out, breaches of the law, and would be reasonably likely to prejudice the effectiveness of those methods and procedures

LEX 528522 March 2018Documents concerning progress of APVMA relocation

6 documents released in full


5 documents released in part

LEX 526921 February 2018Documents relating to compliance activity with respect to products containing dimethoate

3 documents released in full


Edited copies of nine document released


Access refused in relation to one document on the grounds that it did not exist

LEX 526725 January 2018Documents relating to the decision to issue Permit 82744 to the Lord Howe Island Board

4 documents released in full


One edited copy of document released

LEX 510426 September 2017Complaint and general compliance information

27 documents released in full


4 documents released in part

LEX 508029 May 2017Covering memo and other correspondence relating to the APVMA staff BBQ talking points about the APVMA’s relocation to Armidale

3 documents released in full


2 documents released in part

LEX 508118 May 2017Oakton Consulting digital strategy report and all documents relating to this FOI request4 documents released in full
LEX 507716 May 2017Talking points distributed to APVMA staff on 7 April 2017, described as 'BBQ conversations' over move to ArmidaleOne document released in full
LEX 50126 March 2017Complaints about Track Visual Pty t/a Augustine ApprovedOne document released in full
LEX 48591 August 2016Documents recording or evidencing the accessing by any person for any purpose between 6 August 2012 and the date of the request the composition and impurity profile of a certain active constituent3 documents released in part
LEX 47731 July 2016Documents in relation to the permit application for the importation and use of the active constituent Fluridone, and associated communication relating to Penrith Lakes Scheme Water Bodies19 documents released in part
LEX 466117 February 2016The company name(s), the product (s) concerned and more detail regarding the compliance offences contained in the notices mentioned in your regulatory update number 2205 documents released in part
LEX 463013 January 2016Copies of e-mails and attachments sent to/from APVMA employees to/from the following e-mail exchanges: @croplife.org.au and @croplife.org from 1 January 2014, narrowing the search to four keywords: Neonicotinoid(s), glyphosate, atrazine, chlorpyrifos4 documents released in full
LEX 46484 January 2016A list of the products described in the APVMA’s financial report as endocrine system, anabolic steroids and sex hormonesOne document released in full
LEX 45071 September 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  4. The number of probably deaths reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 15
  5. The number of probably deaths reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 15
  6. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  7. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible
    reactions'
  8. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable deaths'
  9. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible deaths'

One document released in full

 

The document can be accessed at: apvma.gov.au/node/15786

LEX 444331 August 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 9 February 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 9 February 2015
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 9 February 2015
  4. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  5. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible reactions'

One document released in full

 

The document can be accessed at: apvma.gov.au/node/15786

LEX 443131 August 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 9 February 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 9 February 2015
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 9 February 2015
  4. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  5. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible reactions'

One document released in full

 

The document can be accessed at: apvma.gov.au/node/15786

LEX 442331 August 2015A copy of an updated report of the numbers and reactions reported to the Hendra vaccine

One document released in full

 

The document can be accessed at: apvma.gov.au/node/15786

LEX 447325 August 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  4. The number of possible deaths reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  5. The number of probably deaths reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 15
  6. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  7. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible reactions'
  8. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable deaths'
  9. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible deaths'

One document released in full

 

The document can be accessed at: apvma.gov.au/node/15786  

LEX 447125 August 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  4. The number of possible deaths reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  5. The number of probably deaths reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 15
  6. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  7. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible reactions'

One document released in full

 

The document can be accessed at: apvma.gov.au/node/15786  

LEX 447025 August 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  4. The number of possible deaths reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  5. The number of probably deaths reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 15
  6. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  7. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible reactions'

One document released in full

 

The document can be accessed at: apvma.gov.au/node/15786  

LEX 446825 August 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 1 June 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 1 June 15
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 1 June 2015
  4. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  5. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible reactions'

One document released in full

 

The document can be accessed at: apvma.gov.au/node/15786  

LEX 444225 August 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and  9 February 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 9 Feb 2015
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 15 and 9 February 15
  4. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  5. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible reactions'

One document released in full

 

The document can be accessed at: apvma.gov.au/node/15786  

LEX 446518 August 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 1 June 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 1 June 2015
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 1 June 2015
  4. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  5. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible reactions'
  6. Information regarding my own horse’s case
5 documents released in full
LEX 438910 August 2015The numbers of reactions to the Equivac Hev vaccine currently being administered under Permits number 14887 and prior Permits 13510 and 14876 reported to the APVMA, and the break-up of those reactions into ‘APVMA Categories’, ie ‘Probable’, ‘Possible’ etc

One document released in full

 

The document can be accessed at: apvma.gov.au/node/15786

LEX 42946 August 2015
  1. the total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January and 9 February 2015
  2. the number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014, and between 1 January 2015 and 9 February 2015
  3. the number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014, and between 1 January 2015 and 9 February 2015
  4. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with ‘probable reactions’
  5. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with ‘possible reactions’
3 documents released in full
LEX 411924 November 2014
  1. any submission made by any third party in relation to the APVMA's invitation (pursuant to section 13 of the Agricultural and Veterinary Chemicals Code Act 1994) for submissions in relation to Startect, dated 12 August 2014 (which expired on 12 September) titled 'Public release summary' (Invitation); and
  2. any communication or information received by the APVMA from a third party in relation to the Invitation.

This request is pursuant to the Agricultural and Veterinary Chemicals Code Act 1994 (specifically section 8W(1)) and Freedom of Information Act 1982

Two submissions released – one in full, one in part
G1123329 August 2014Scientific evidence that demonstrates the efficacy of certain APVMA registered pool sanitisers in respect of the 2014 APVMA guidelines

Documents do not exist


Decision

G109686 May 2014Correspondence between the APVMA and Fruit West between 1 January 2012 and 1 January 2014Emails, letters and notices released in part
G1095314 April 2014Adverse experience report prepared by Intervet Australia Pty Ltd (trading as MSD Animal Health) received by the APVMA in 2012 and related correspondence regarding AnguiMonas vaccine (PER12623)Adverse experience report and correspondence released in part
G107833 December 2013Information concerning trials for Tri-solfen (60099)Dose determination study on a topical local anaesthetic preparation for use in sheep, field study to evaluate the safety and efficacy of a topical local anaesthetic spray for use in sheep, and safety evaluation on a topical local anaesthetic preparation for use in sheep released in part
G1048916 October 2013Unfiltered data (copies of all adverse experience forms marked ‘Lack of effect/poor efficacy’) lodged between 1 January and 31 December 2010 by veterinarians, pet owners and manufacturers for CPV-2 antigen-containing vaccines administered to dogs of all agesAdverse experience reports submitted to the APVMA relating to CPV-2 antigen-containing vaccines released in part
G106272 August 2013Notice of registration, finished product specifications, approved shelf life and storage conditions for Calefur Sterile Powder for Injection (62682)Notice of Registration and Approval of Label Under the Agvet Codes released in part
G106262 August 2013Notice of registration, finished product specifications, approved shelf life and storage conditions for Caleflunix Injection (63989)Notice of Registration and Approval of Label Under the Agvet Codes released in part
G106252 August 2013Notice of registration, finished product specifications, approved shelf life and storage conditions for Calesed Injection (63855)Notice of Registration and Approval of Label Under the Agvet Codes released in part
G106242 August 2013Notice of registration, finished product specifications, approved shelf life and storage conditions for Caledoxy 100 Tablets (62220)Notice of Registration and Approval of Label Under the Agvet Codes released in part
G1063117 July 2013Notice of registration, finished product specifications, approved shelf life and storage conditions for Juroclav 500 Broad Spectrum Antibiotic Tablets (61671)Notice of Registration and Approval of Label Under the Agvet Codes released in part
G1063017 July 2013Notice of registration, finished product specifications, approved shelf life and storage conditions for Juroclav 250 Broad Spectrum Antibiotic Tablets (61670)Notice of Registration and Approval of Label Under the Agvet Codes released in part
G1062917 July 2013Notice of registration, finished product specifications, approved shelf life and storage conditions for Juroclav 50 Broad Spectrum Antibiotic Tablets (61669)Notice of Registration and Approval of Label Under the Agvet Codes released in part
G1048917 July 2013Unfiltered data (copies of all adverse experience forms) lodged between 1 January and 31 December 2010 by veterinarians, pet owners and manufacturers, for CPV-2 antigen-containing vaccines administered to dogs of all agesAdverse experience reports submitted to the APVMA relating to CPV-2 antigen-containing vaccines released in part

Contact

View our contact information for freedom of information enquiries.

See also: information about making a request.

Content last updated:
Content last reviewed: